289 related articles for article (PubMed ID: 25309884)
1. Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi.
Guimarães LL; Toledo MS; Ferreira FA; Straus AH; Takahashi HK
Front Cell Infect Microbiol; 2014; 4():138. PubMed ID: 25309884
[TBL] [Abstract][Full Text] [Related]
2. Biological Roles Played by Sphingolipids in Dimorphic and Filamentous Fungi.
Fernandes CM; Goldman GH; Del Poeta M
mBio; 2018 May; 9(3):. PubMed ID: 29764947
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.
Toledo MS; Tagliari L; Suzuki E; Silva CM; Straus AH; Takahashi HK
BMC Microbiol; 2010 Feb; 10():47. PubMed ID: 20156351
[TBL] [Abstract][Full Text] [Related]
4. Current relevance of fungal and trypanosomatid glycolipids and sphingolipids: studies defining structures conspicuously absent in mammals.
Takahashi HK; Toledo MS; Suzuki E; Tagliari L; Straus AH
An Acad Bras Cienc; 2009 Sep; 81(3):477-88. PubMed ID: 19722017
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of glycosylinositol phosphorylceramides from fungi by electrospray tandem mass spectrometry with low-energy collision-induced dissociation of Li(+) adduct ions.
Levery SB; Toledo MS; Straus AH; Takahashi HK
Rapid Commun Mass Spectrom; 2001; 15(23):2240-58. PubMed ID: 11746891
[TBL] [Abstract][Full Text] [Related]
6. Glycosphingolipids of the model fungus Aspergillus nidulans: characterization of GIPCs with oligo-alpha-mannose-type glycans.
Bennion B; Park C; Fuller M; Lindsey R; Momany M; Jennemann R; Levery SB
J Lipid Res; 2003 Nov; 44(11):2073-88. PubMed ID: 12923229
[TBL] [Abstract][Full Text] [Related]
7. Glycosylinositol phosphorylceramides from Rosa cell cultures are boron-bridged in the plasma membrane and form complexes with rhamnogalacturonan II.
Voxeur A; Fry SC
Plant J; 2014 Jul; 79(1):139-49. PubMed ID: 24804932
[TBL] [Abstract][Full Text] [Related]
8. Characterization of neutral and acidic glycosphingolipids from the lectin-producing mushroom, Polyporus squamosus.
Arigi E; Singh S; Kahlili AH; Winter HC; Goldstein IJ; Levery SB
Glycobiology; 2007 Jul; 17(7):754-66. PubMed ID: 17395693
[TBL] [Abstract][Full Text] [Related]
9. Glycosphingolipids in Filamentous Fungi: Biological Roles and Potential Applications in Cosmetics and Health Foods.
Jiang C; Ge J; He B; Zeng B
Front Microbiol; 2021; 12():690211. PubMed ID: 34367090
[TBL] [Abstract][Full Text] [Related]
10. Glucosylceramide synthase and glycosphingolipid synthesis.
Ichikawa S; Hirabayashi Y
Trends Cell Biol; 1998 May; 8(5):198-202. PubMed ID: 9695839
[TBL] [Abstract][Full Text] [Related]
11. Glycosylinositolphosphoceramides in Aspergillus fumigatus.
Simenel C; Coddeville B; Delepierre M; Latgé JP; Fontaine T
Glycobiology; 2008 Jan; 18(1):84-96. PubMed ID: 17971386
[TBL] [Abstract][Full Text] [Related]
12. Characterization of sphingolipids from mycopathogens: factors correlating with expression of 2-hydroxy fatty acyl (E)-Delta 3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus.
Toledo MS; Levery SB; Straus AH; Suzuki E; Momany M; Glushka J; Moulton JM; Takahashi HK
Biochemistry; 1999 Jun; 38(22):7294-306. PubMed ID: 10353841
[TBL] [Abstract][Full Text] [Related]
13. Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.
Mota Fernandes C; Del Poeta M
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1083-1092. PubMed ID: 32673125
[TBL] [Abstract][Full Text] [Related]
14. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
15. Analysis of glycosylinositol phosphorylceramides expressed by the opportunistic mycopathogen Aspergillus fumigatus.
Toledo MS; Levery SB; Bennion B; Guimaraes LL; Castle SA; Lindsey R; Momany M; Park C; Straus AH; Takahashi HK
J Lipid Res; 2007 Aug; 48(8):1801-24. PubMed ID: 17488996
[TBL] [Abstract][Full Text] [Related]
16. Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis: an immunodominant beta-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen.
Levery SB; Toledo MS; Straus AH; Takahashi HK
Biochemistry; 1998 Jun; 37(24):8764-75. PubMed ID: 9628738
[TBL] [Abstract][Full Text] [Related]
17. Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids.
Mor V; Rella A; Farnoud AM; Singh A; Munshi M; Bryan A; Naseem S; Konopka JB; Ojima I; Bullesbach E; Ashbaugh A; Linke MJ; Cushion M; Collins M; Ananthula HK; Sallans L; Desai PB; Wiederhold NP; Fothergill AW; Kirkpatrick WR; Patterson T; Wong LH; Sinha S; Giaever G; Nislow C; Flaherty P; Pan X; Cesar GV; de Melo Tavares P; Frases S; Miranda K; Rodrigues ML; Luberto C; Nimrichter L; Del Poeta M
mBio; 2015 Jun; 6(3):e00647. PubMed ID: 26106079
[TBL] [Abstract][Full Text] [Related]
18. Novel neogala-series glycosphingolipids with a terminal glucose residue from the fungus Mariannaea elegans.
Tani Y; Nakamura K; Sawa R; Nishio M; Saito S; Ito M; Itonori S; Mihara H
Biosci Biotechnol Biochem; 2013; 77(4):754-9. PubMed ID: 23563544
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends.
Hakomori SI
Biochim Biophys Acta; 2008 Mar; 1780(3):325-46. PubMed ID: 17976918
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids as targets for treatment of fungal infections.
Rollin-Pinheiro R; Singh A; Barreto-Bergter E; Del Poeta M
Future Med Chem; 2016 Aug; 8(12):1469-84. PubMed ID: 27502288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
